Alessia Tacito
Pisa, 56124, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion.
Journal: Case reports in endocrinology
Published: January 14, 2020
Medullary thyroid cancer treated with vandetanib: predictors of a longer and durable response.
Journal: Endocrine-related cancer
Published: June 07, 2019
Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing.
Journal: iScience
Published: May 20, 2019
Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
Journal: Annales d'endocrinologie
Published: May 05, 2019
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience.
Journal: Oncology letters
Published: September 02, 2017
RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases.
Journal: Oncotarget
Published: August 09, 2017
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland.
Journal: Journal of endocrinological investigation
Published: May 31, 2016
New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations.
Journal: Journal of medical genetics
Published: February 11, 2016
Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
Journal: Clinical endocrinology
Published: August 04, 2014
Low prevalence of the somatic M918T RET mutation in micro-medullary thyroid cancer.
Journal: Thyroid : official journal of the American Thyroid Association
Published: March 13, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026